BioNTech
New tranche of Pfizer BioNtech vaccine to arrive at Otopeni airport
A new tranche of the Pfizer BioNTech vaccine, 662,220 doses, will arrive at the Otopeni airport on Monday, the National Coordinating Committee for Vaccination Activities against COVID-19 informs in a press release sent to AGERPRES. The transportation of the vaccine doses to the storage centre is provided by the manufacturing company, including by land.
Turkey gives over half a million COVID-19 vaccine shots in 24 hours
Turkey has administered over half a million doses of COVID-19 vaccines in the last 24 hours, according to figures released on July 17.
The country continues its vaccination campaign, which began this January, to curb the spread of the virus, as all residents 18 and over are eligible for vaccine shots.
Study Compares Pfizer-BioNTech and Sinovac Vaccines
People who receive a COVID vaccine from Pfizer-BioNTech produce 10 times more antibodies than those who opted for Sinovac's CoronaVac, a Chinese drug. This was reported on Friday, July 16 by South China Morning Post with reference to relevant research.
COVID-19 vaccination campaign: 12,082 people immunised in 24h
Bucharest, July 12 /Agerpres/ - Romania's National COVID-19 Vaccination Coordination Committee (CNCAV) reports that 12,082 doses of vaccine have been administered in the past 24 hours, of which 7.395 being the first dose and 4,687 the second dose, CNCAV reports on Monday.
CoronaVac vaccine 83.5 percent effective: Turkish study
Interim results from a phase 3 trial in Turkey have shown that two doses of CoronaVac, a vaccine developed by the Chinese firm Sinovac, are 83.5 percent effective against symptomatic COVID-19.
COVID-19: Pfizer Suggests Third Dose Booster against Delta Variant for Vaccinated
Pfizer is preparing a third booster Covid shot to take on the deadly Delta variant, the company revealed.
The pharma corporation is seeking emergency authorization from the US FDA for another jab to be administered six-to-twelve months after full vaccination.
Pfizer pushes for 3rd shot as variant drives global outbreaks
Pfizer and BioNTech announced on July 8 they would seek authorization for a third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and cases rose again in Europe and the United States.
Jabs given in Turkey valid for vaccine certificates, says health minister
Jabs administered in Turkey against COVID-19 are valid for vaccine certificates in the countries Ankara has agreements with for the reciprocal recognition of those certificates, Health Minister Fahrettin Koca has said.
Growing number of newly infected, but a drop in the number of deaths
281 people were hospitalized, 11 of them are on a respirator.
So far, 716.983 coronavirus positive cases have been registered in Serbia out of 4.450.741 tested.
As a result of the infection, 7.059 patients died, and the mortality rate was 0.98.
Over 25 pct of Turkish population aged over 18 fully vaccinated
With the administration of more than 5.3 million doses of COVID-19 jabs over the past week alone, a little over 25 percent of Turkey's population aged over 18 is now fully inoculated.